recurrent mantle cell lymphoma
Showing NaN - NaN of 19
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Low Dose Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Biospecimen Collection, Follow-Up)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Biospecimen Collection
- Follow-Up
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Blastoid Variant Mantle Cell Lymphoma, CCND1 Protein Overexpression, CD20 Positive Trial in Houston (Acalabrutinib, Venetoclax)
Recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Blastoid Variant Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Follicular Lymphoma Trial in United
Active, not recruiting
- Blastoid Variant Mantle Cell Lymphoma
- +8 more
- Ibrutinib
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +4 more
May 10, 2022
CNS Lymphoma, Gastric Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Houston (Akt/ERK Inhibitor ONC201,
Terminated
- Central Nervous System Lymphoma
- +6 more
- Akt/ERK Inhibitor ONC201
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 30, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Eprenetapopt, Venetoclax)
Withdrawn
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
-
Houston, TexasM D Anderson Cancer Center
Feb 23, 2022
CCND1 Positive, CCND2 Positive, CCND3 Positive Trial in Houston (drug, other, biological)
Active, not recruiting
- CCND1 Positive
- +6 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 11, 2022
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic
Terminated
- B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
- +16 more
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 28, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Best Practice, Ibrutinib, Patient Derived
Unknown status
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Best Practice
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2020
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Ixazomib, Ixazomib Citrate, Rituximab)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Ixazomib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
-
Birmingham, Alabama
- +19 more
Jan 7, 2016
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Houston (recombinant
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +16 more
- recombinant interleukin-12
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Apr 14, 2015
Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Intraocular Lymphoma Trial in Houston (oblimersen sodium, rituximab, laboratory
Completed
- Cutaneous B-cell Non-Hodgkin Lymphoma
- +20 more
- oblimersen sodium
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2014
Anaplastic Large Cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Chicago,
Completed
- Anaplastic Large Cell Lymphoma
- +5 more
-
Chicago, Illinois
- +1 more
May 7, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +61 more
- bevacizumab
- cediranib maleate
-
Houston, TexasM D Anderson Cancer Center
Feb 14, 2014
Contiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Stage III Mantle Cell Lymphoma Trial in
Withdrawn
- Contiguous Stage II Mantle Cell Lymphoma
- +4 more
- antineoplaston A10
- +7 more
-
Houston, TexasBurzynski Clinic
Jul 9, 2013
Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (oxaliplatin)
Completed
- Angioimmunoblastic T-cell Lymphoma
- +16 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013